Advertisement
Home »

TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway.

May 22, 2023

ABOUT THE EXPERTS

  • Jing Man

    School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

    Wanbiao Zhou

    School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

    Shi Zuo

    School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

    Xueke Zhao

    Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China. Electronic address: zhaoxueke1@163.com.

    Qiang Wang

    Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

    Huaxing Ma

    Department of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China.

    Hai-Yang Li

    School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China; Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Peoples Republic of China. Electronic address: lihaiyang@gmc.edu.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement